Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chinese herbal formula No.2
- Development stage
- Preclinical
- Lead developer
- Yunnan Provincial Hospital of Traditional Chinese Medicine
- Administration
- Oral
01
Overview
Chinese herbal formula No.2 is a traditional Chinese medicine (TCM) preparation developed by the Yunnan Provincial Hospital of Traditional Chinese Medicine. It is currently being evaluated in clinical trials as an adjunctive treatment for patients with active rheumatoid arthritis who are undergoing glucocorticoid tapering. The formula is used in combination with standard disease-modifying antirheumatic drugs (DMARDs), such as methotrexate and leflunomide, and the corticosteroid prednisone. The primary objective of incorporating this herbal formula is to reduce the cumulative dose of glucocorticoids required to maintain disease control, minimize the risk of relapse during steroid withdrawal, and improve overall safety and disease activity scores (e.g., DAS28-ESR). As a TCM intervention, it is likely composed of a standardized mixture of botanical extracts tailored to specific arthritic patterns recognized in traditional medicine.
- Other names
- TCM formula No.2Chinese herbal formula No. 2
Beyond the preview
Go deeper on Chinese herbal formula No.2.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chinese herbal formula No.2.